Everpure CEO Giancarlo Charles H Sells 70,000 Shares

What Happened

• Giancarlo Charles H, CEO and director of Everpure, sold a total of 70,000 shares on August 10, 2026 in a series of open‑market/private sales. The eight reported lots ranged in size and price, producing aggregate proceeds of approximately $6,925,759 (~$6.93M). The sales were executed under a Rule 10b5‑1 trading plan adopted September 26, 2025 (footnote F1) and include shares held by the Giancarlo Family Trust (F10).
• These were outright sales (S), not purchases, awards, or option exercises. Sales like this are often routine liquidity events; they do not by themselves prove CEO view on company prospects.

Key Details

• Transaction date: August 10, 2026; Form 4 filed August 12, 2026 (filed within the usual two‑business‑day window).
• Individual lots reported:
  • 700 shares @ $94.63 — $66,241
  • 600 shares @ $96.01 — $57,606
  • 1,600 shares @ $97.33 — $155,728
  • 30,800 shares @ $98.50 — $3,033,800
  • 30,601 shares @ $99.27 — $3,037,761
  • 3,600 shares @ $100.41 — $361,476
  • 1,899 shares @ $101.50 — $192,749
  • 200 shares @ $101.99 — $20,398
• Prices reported are weighted averages for multiple executions; per footnotes (F2–F9) the execution prices ranged roughly from $94.47 up to $102.03 across the lots. The reporting person will provide breakdowns upon request (per footnotes).
• Shares owned after transaction: not provided in the excerpt — check the full Form 4 for post‑sale holdings.
• Notable footnotes: F1 (transactions under a 10b5‑1 plan adopted 9/26/2025); F10 (some shares held by Giancarlo Family Trust); F2–F9 (weighted‑average pricing ranges for the lots).

Context

• Trades executed under an established 10b5‑1 plan are pre‑arranged and often indicate the sales were scheduled in advance, which can make them less informative about the insider’s current view of the company.
• These were sales, not option exercises, awards, or gifts. For retail investors, purchases typically carry more weight as positive signals; routine or pre‑planned sales are common for liquidity or diversification. Check the full Form 4 (accession 0001474432-26-000081) for complete holdings and any additional disclosures.